Pfizer says its vaccine is effective against the British variant of Covid-19

The pharmaceutical company published a study in support of the University of Texas, where 20 volunteers who suffered from this new strain and had received the vaccine made with BioNtech were tested.

A study conducted by Pfizer and the University of Texas determined that the vaccine produced by the pharmaceutical company and BioNTech is effective against the Covid-19 mutations discovered in the United Kingdom and South Africa.

The Covid-19 mutation discovered in the United Kingdom has humanity pending, because it is considered 70% more contagious. Several countries in the world have already established restrictions with the European power.

The study that claims a historical effectiveness of Pfizer has not yet been reviewed by other scientists, however, you can access it and leave a comment on the portals where it was published.

The study was conducted with 20 volunteers who suffered from this new variant, but had received the Pfizer vaccine. Research is also being carried out to find out if any vaccine compound should be changed in the future, in the face of possible new strains.

This new strain has already become the predominant coronavirus across the UK. European countries, for now, have broken all ties with the nation, while in other parts of the world restriction measures are also taken.

Be the first to comment

Leave a Reply

Tu dirección de correo no será publicada.


*